je.st
news
Tag: extract
FDA Approves Mercks RAGWITEK (Short Ragweed Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Short Ragweed Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Adults
2014-04-18 00:22:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. RAGWITEK is the First and Only FDA Approved Sublingual Allergen Immunotherapy Tablet Indicated for the Treatment of Short Ragweed Pollen Allergies WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved RAGWITEK (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use (12 Amb a 1-U). Language: English Contact: MerckMedia Contacts:Pamela Eisele, 267-305-3558Robert Consalvo, 908-423-6595orInvestor Contacts:Carol Ferguson, 908-423-4465Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: without
short
treat
adults
FDA Approves Mercks GRASTEK (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults
2014-04-14 23:59:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. GRASTEK is the Only FDA Approved Sublingual Allergy Immunotherapy Tablet Indicated for Children as Young as 5 Years of Age WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved GRASTEK (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use [2800 Bioequivalent Allergy Units (BAU)]. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: without
children
treat
adults
Act fast to curb global warming, or extract CO2 from air: UN
2014-04-13 16:00:00| Climate Ark Climate Change & Global Warming Newsfeed
Reuters: A United Nations report said on Sunday that governments must act faster to slow global warming and delays until 2030 could force reliance on little-tested technologies to extract greenhouse gases from the air. The study, drawing on work by more than 1,000 experts, said a radical shift from conventional fossil fuels to low-carbon energy such as wind, solar or nuclear power would shave only about 0.06 percentage point a year off world economic growth. "It does not cost the world to save the planet,"...
Act fast curb global warming or extract CO2 from air: UN
2014-04-13 11:05:00| Climate Ark Climate Change & Global Warming Newsfeed
Reuters: The study, drawing on the work of more than 1,000 experts, said a shift from fossil fuels to low-carbon energy such as wind, solar or nuclear power was affordable and would shave only about 0.06 percentage point a year off world economic growth. "We have a window of opportunity for the next decade, and maximum the next two decades" to act at moderate costs, said Ottmar Edenhofer, co-chair of a Berlin meeting of the Intergovernmental Panel on Climate Change (IPCC). "I'm not saying it's costless....
Merck Announces Canadian Approval of GRASTEK (Standardized Allergenic Extract, Timothy Grass (Phleum pratense) Sublingual Tablet)
2014-02-03 14:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. GRASTEK (Timothy Grass Pollen Allergen Extract) Remains Under FDA Review in the United States WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the regulatory approval and launch of GRASTEK (Timothy grass pollen allergen extract) sublingual tablets in Canada. This represents the first approval of GRASTEK for Merck. The product is currently marketed by ALK-Abello in Europe as GRAZAX. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: approval
canadian
grass
extract
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »